Search - tctmd.com

Displaying 101 - 120 of 255

Sort: Relevancy | Date

Presentation TCT 2017

Percutaneous Mitral Valve-in Valve Implantation With SAPIEN 3 Prosthesis Using an Anterograde Transvenous Transseptal Approach

Presenter: Vasilis Babaliaros, Shmuel Banai, Caterina Gandolfo

October 30, 2017

Presentation TCT 2017

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

Presenter: Robert O. Bonow, Michael J. Mack, Maurice E. Sarano

October 30, 2017

Presentation TCT 2017

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Presenter: Uzoma Ibebuogu

October 30, 2017

Presentation TCT 2017

Point A Tiered Centers of Excellence Approach Makes Sense!

Presenter: Patrick T. O'Gara

October 30, 2017

Presentation TCT 2017

Intracardiac Endoscopic View of a Step by Step Transcatheter Mitral Valve Implant and Tricuspid Regurgitation Transcatheter Treatment in a Beating Porcine Heart

Presenter: Vasilis Babaliaros, Shmuel Banai, Guido Gelpi

October 30, 2017

Presentation TCT 2017

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Presenter: Martin B. Leon

October 30, 2017

Presentation TCT 2017

Point - Clearly, The More You Do, The Better You Are!

Presenter: John D. Carroll

October 30, 2017

Presentation TCT 2017

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood

October 30, 2017

Presentation TCT 2017

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Michael J. Mack, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Presenter: Robert O. Bonow, Michael J. Mack, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Germany Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther

October 30, 2017

Presentation TCT 2017

Czech Republic Comments: How Would I Treat This Case and Why?

Presenter: Petr Kala, Jochen Wöhrle, Marian Branny

October 30, 2017

Presentation TCT 2017

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Presenter: Petr Kala, Jochen Wöhrle, Martin Hudec

October 30, 2017

Presentation TCT 2017

Tricuspid Valve Disease and TTV Repair and Replacement: Progress and Obstacles

Presenter: Russell A. Brandwein

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

Presenter: Russell A. Brandwein, Elizabeth M. Perpetua

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Advertisement

Percutaneous Mitral Valve-in Valve Implantation With SAPIEN 3 Prosthesis Using an Anterograde Transvenous Transseptal Approach

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Point A Tiered Centers of Excellence Approach Makes Sense!

Intracardiac Endoscopic View of a Step by Step Transcatheter Mitral Valve Implant and Tricuspid Regurgitation Transcatheter Treatment in a Beating Porcine Heart

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Point - Clearly, The More You Do, The Better You Are!

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Germany Comments: How Would I Treat This Case and Why?

Czech Republic Comments: How Would I Treat This Case and Why?

Slovakia Presents: Current Knowledge Impact of Coronary Artery Disease on TAVR Management and Outcomes

Tricuspid Valve Disease and TTV Repair and Replacement: Progress and Obstacles

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

TAVR Patient Journey V: Addressing Complications and Follow-up

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content